2.7 bil....that will get them half way to building T2!!!!
They are at 2.25 billion which if diluted will provide another $5.1 million cash from options.
T1 pays for itself....
G2 pays for anything outside of T2 you like...plus the $5 mill from options
So your looking at a scenario where you have 2.25 billion plus 85 million Lind shares to add at 3.5c...= 2.335 billion
2 year plan = $5 million plus cash from ops
$10-20 profits from G2....Total cash for 2 years is $15-25 million with all T1 upside and DFD paid for from T1 proceedings.
T1 all the way to dfs = upside
$15-25 million cash for 2 years development of Granville, Mt Cobalt and Pmebroke = Upside.
Toward the end of the 2 year period what will the share price be on a decision to min Taronga and 2.335 billion shares.
DFS, Mt Cobalt and Pemproke Jorc, more cash coming out of Granville.....
At 20c a share and 500m mc which the DFs and Mt Cobalt, Pembroke Jorc and Granville LOM/JV....every 100 mil shares is $20 million dollars...
Your 2.7 billion gives us the whole capex for T2 if its played right and only a $520 million MC for a built monster....
- Forums
- ASX - By Stock
- C7A
- Ann: Positive Results for Taronga Ore-sorting Test Work
Ann: Positive Results for Taronga Ore-sorting Test Work, page-202
-
-
- There are more pages in this discussion • 135 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add C7A (ASX) to my watchlist
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.802M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 404887 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 329569 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 404887 | 0.017 |
4 | 249716 | 0.016 |
3 | 335000 | 0.015 |
1 | 250000 | 0.014 |
1 | 520149 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 329569 | 4 |
0.020 | 300000 | 1 |
0.021 | 50000 | 1 |
0.022 | 543000 | 3 |
0.023 | 185758 | 1 |
Last trade - 10.02am 16/07/2024 (20 minute delay) ? |
Featured News
C7A (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online